Edition:
United Kingdom

Nanobiotix SA (NANOB.PA)

NANOB.PA on Paris Stock Exchange

15.14EUR
23 Oct 2018
Change (% chg)

€-0.52 (-3.32%)
Prev Close
€15.66
Open
€15.51
Day's High
€15.51
Day's Low
€15.03
Volume
23,082
Avg. Vol
185,757
52-wk High
€18.87
52-wk Low
€8.30

Chart for

About

Nanobiotix SA is a France-based oncology focused nanomedicine company. It is engaged in developing nanoparticle technology. It develops new tools for cancer which utilize a physical mode of action at the cellular level of the cancer cell. This disruptive approach may reshape future treatment opportunities. The Company's NanoXray... (more)

Overall

Beta: 1.61
Market Cap(Mil.): €301.54
Shares Outstanding(Mil.): 17.56
Dividend: --
Yield (%): --

Financials

  NANOB.PA Industry Sector
P/E (TTM): -- 85.41 33.64
EPS (TTM): -1.51 -- --
ROI: -72.64 0.21 14.27
ROE: -81.91 1.17 15.99

BRIEF-Nanobiotix Did Not Generate Any Revenue In Q1

* ANNOUNCED ON TUESDAY IT DID NOT GENERATE ANY REVENUE FOR Q1 2018, AS IT HAD EXPECTED

16 May 2018

BRIEF-Nanobiotix Partners With Weill Cornell Medicine

* PARTNERSHIP ON PRE-CLINICAL STUDIES TO EVALUATE NBTXR3 IMPACT ON CGAS-STING PATHWAY IN MAMMARY CANCERS

03 May 2018

Earnings vs. Estimates